Not applicableUnknownNCT04076111What this trial is testingPatterns of Breast Cancer Management and Prognosis of Breast Cancer in ChinaWho this might be right forBreast Cancer Fengxi Su 20,000
Not applicableStudy completedNCT03578107What this trial is testingImprove Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in ChinaWho this might be right forIschemic Stroke Beijing Tiantan Hospital 15,895
Post-approval studies (Phase 4)Study completedNCT05134571What this trial is testingChina Post-marketing Surveillance (PMS) Study of Aldurazyme®Who this might be right forMucopolysaccharidosis I Genzyme, a Sanofi Company 12
Not applicableNot Yet RecruitingNCT07789925What this trial is testingSphere-9 PAF China StudyWho this might be right forParoxysmal Atrial Fibrillation (PAF) Medtronic Cardiac Ablation Solutions 180
Not applicableNot Yet RecruitingNCT07718035What this trial is testingEvaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compassion FatigueWho this might be right forCompassion Fatigue University of Malaya 60
Not applicableUnknownNCT04320368What this trial is testingChina Alzheimer's and Neurodegenerative Disorder ResearchWho this might be right forCognitive Impairment Beijing Tiantan Hospital 3,100
Not applicableStudy completedNCT04351035What this trial is testingNational Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 RegistryWho this might be right forTumors, Central Nervous SystemPediatric Brain TumorMalignant Brain Tumor+1 more Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 4,303
Not applicableUnknownNCT04197674What this trial is testingChina Q Cohort StudyWho this might be right forEnd Stage Renal Disease on DialysisPeritoneal DialysisHemodialysis Sun Yat-sen University 903
Not applicableStudy completedNCT02316990What this trial is testingChina Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical PatientsWho this might be right forStress UlcersStress-related Mucosal Disease (SRMD) AstraZeneca 1,416
Not applicableLooking for participantsNCT06676137What this trial is testingAn Observational Study of Coronary Microvascular Disease of ChinaWho this might be right forCoronary Microvascular Disease Henan Institute of Cardiovascular Epidemiology 500
Not applicableStudy completedNCT04588337What this trial is testingINtravenous TNK for Acute isChemicsTroke in ChinaWho this might be right forStroke, Ischemic General Hospital of Shenyang Military Region 1,000
Not applicableEnrolling By InvitationNCT04989751What this trial is testingPhenotype-Genotype Analysis of LGMD Patients in ChinaWho this might be right forLGMDLGMDR2LGMDR1 Huashan Hospital 450
Early research (Phase 1)UnknownNCT04976751What this trial is testingReal World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest ChinaWho this might be right forChronic Pelvic PainChronic Prostatitis Xijing Hospital 274
Not applicableStudy completedNCT03884621What this trial is testingEnhanced Post-discharge Home-based Care Program (EHP) for Stroke Survivors in Harbin ChinaWho this might be right forStroke The Hong Kong Polytechnic University 144
Not applicableStudy completedNCT03451721What this trial is testingObservation of ImageReady™ MR Conditional Defibrillation System in ChinaWho this might be right forArrhythmia Boston Scientific Corporation 20
Testing effectiveness (Phase 2)Study completedNCT05046314What this trial is testingA Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's SarcomaWho this might be right forSarcoma, Ewing Shanghai Pharmaceuticals Holding Co., Ltd 15
Not applicableStudy completedNCT06053801What this trial is testingA Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in ChinaWho this might be right forChronic Spontaneous Urticaria Novartis Pharmaceuticals 55
Large-scale testing (Phase 3)Study completedNCT01214239What this trial is testingEfficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic ControlWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 300
Not applicableStudy completedNCT03808272What this trial is testingAXIOS CHINA (E7148)Who this might be right forPancreatic Pseudocyst and Walled-off Necrosis Boston Scientific Corporation 31
Not applicableActive Not RecruitingNCT05828186What this trial is testingCRUSTAL Study in ChinaWho this might be right forCoronary Artery DiseaseCalcification First Affiliated Hospital of Guangxi Medical University 200